ŞENER, Y. Z. 2020. Comment on: "Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study". TARGETED ONCOLOGY , vol.15, no.3 , 411.

ŞENER, Y. Z., (2020). Comment on: "Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study". TARGETED ONCOLOGY , vol.15, no.3, 411.

ŞENER, YUSUF. "Comment on: "Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study"," TARGETED ONCOLOGY , vol.15, no.3, 411, 2020

ŞENER, YUSUF Z. . "Comment on: "Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study"." TARGETED ONCOLOGY , vol.15, no.3, pp.411, 2020

ŞENER, Y. Z. (2020) . "Comment on: "Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study"." TARGETED ONCOLOGY , vol.15, no.3, p.411.

@article{article, author={YUSUF ZİYA ŞENER}, title={Comment on: "Regorafenib-Induced Hypothyroidism as a Predictive Marker for Improved Survival in Metastatic or Unresectable Colorectal Cancer Refractory to Standard Therapies: A Prospective Single-Center Study"}, journal={TARGETED ONCOLOGY}, year=2020, pages={411} }